Questions Compiled by Agoracom Resverlogix Shareholders

1) What is the status of BETonMACE study site activation and enrollment? It is hard to tell from ClinicalTrials.gov or EU Clinical Trials register what the actual status is since these are infrequently updated.

2) What is the timeline and estimated launch date of the RVX-208 Phase 2 PNH trial? Is a H1 2016 trial start still a possibility?

3) What is the number of and timeline for other RVX-208 orphan disease trials as alluded to in the recent blog video? Will these happen concurrent with the PNH trial?

4) What are the plans for the Alzheimer's trial that seems to keep getting kicked down the road? In the September Corporate Update, RVX discussed how the complement pathway is now being appreciated to be involved in Alzheimer's progression, so seems like there should be renewed interest.

5) How is the collaboration going with university in Colorado (can't remember which one) to analyze up to 1300 plasma proteins in the ASSERT trial samples? Ewalina Kulikowski talked about this in the September Corporate Update.

6) What are the plans for RVX-208 follow on molecules? Will these be for MACE/Athero or other indications? What kind of pre-clinical data has been collected on these?

7) What are the plans for Nasdaq listing?

8) Are there other licensing deals in the works?

9) Can you provide a financial update: How will upcoming trials be financed? How will the Citibank/Eastern Capital loan will be paid off next year? Will there be any future dilution? If so, when and how much? What is the current employee count, cash on hand and cash burn rate?

10) What is status of Hepalink agreement. For example, will China still have patients in BETonMACE? How is China economy affecting things if at all?

11) How are discussion with FDA for BETonMACE going? Still ongoing? Finished? Any chance for US study sites/patients in BETonMACE?

12) What conferences are Resverlogix planning to attend in 2016?

13) Are there scientific manuscripts in preparation?

14) What is the estimate for when the BETonMACE 125 event interim analysis might occur?

15) What is management's plan for increasing shareholder knowledge and interest in this stock? What is management doing to get the word out regarding BetOnMace, the company, the formula, etc.?